Faculty Position - Department of Epidemiology and Cancer Control

St. Jude Children's Research Hospital•Memphis, TN

About The Position

The Department of Epidemiology and Cancer Control at St. Jude Children’s Research Hospital is recruiting Faculty Members at the FULL, ASSOCIATE or ASSISTANT level as we expand our Department’s mission to conduct highly innovative clinical, biological, and population-health sciences research (both observational and interventional studies), and translate our findings into effective strategies to avert or mitigate cancer-treatment-related complications and improve the quality of life of childhood cancer survivors. We are seeking creative and collaborative scientists with vibrant research programs as we grow and further expand the mission. Our research uses state-of-art approaches to assess/evaluate adverse outcomes and to design interventions to optimize health. Our Department and associated Cancer Center Programs in the St. Jude Comprehensive Cancer Center, include a diverse team of investigators with expertise in epidemiology/biostatistics, oncology/cardiology/neurology/nursing, genetics/bioinformatics, psychology/neuropsychology, exercise science/rehabilitation, symptoms/patient-reported outcomes, and health behavior/health services research. We actively collaborate across Cancer Center Programs, engaging with both clinic- and laboratory-based researchers to advance clinical care and knowledge on childhood cancer and associated late effects, encompassing biological, clinical, and social determinants and mechanisms. Our Department is home to both the Childhood Cancer Survivor Study with over 38,000 childhood cancer survivors diagnosed from 1970-1999 in North America, and the St. Jude Lifetime Cohort with over 6000 clinically assessed childhood cancer survivors treated at St. Jude Children’s Research Hospital since 1962. These foundational studies are funded by the National Cancer Institute (NCI) and are unparalleled resources for research, with comprehensive characterizations of cancer treatment exposures/doses, whole genome/whole exome sequencing of germline genomes, patient-reported outcomes, and an extensive array of clinically-, laboratory- and survey-ascertained late effects outcomes and measurements. Our Department encompasses a strong T32 Postdoctoral program, >170 staff members who support maintaining and expanding activities of the two cohort studies and many ongoing R01-equivalent projects which are built on the two cohort studies.